REAL Centre, The Health Foundation, London, UK
Public Health, Environments and Society, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
BMJ Open. 2022 Mar 24;12(3):e059374. doi: 10.1136/bmjopen-2021-059374.
We explore the routes to cancer diagnosis to further undertanding of the inequality in the reduction in detection of new cancers since the start of the pandemic. We use different data sets to assess stages in the cancer pathway: primary care data for primary care consultations, routine and urgent referrals and published analysis of cancer registry data for appointments and first treatments.
Primary and cancer care.
In this study we combine multiple data sets to perform a population-based cohort study on different areas of the cancer pathway. For primary care analysis, we use a random sample of 5 00 000 patients from the Clinical Practice Research Datalink. Postreferral we perform a secondary data analysis on the Cancer Wait Times data and the National Cancer Registry Analysis Service COVID-19 data equity pack.
Primary care: consultation, urgent cancer referral and routine referral rates, then appointments following an urgent cancer referral, and first treatments for new cancer, for all and by quintile of patient's local area index of multiple deprivation.
Primary care contacts and urgent cancer referrals in England fell by 11.6% (95% CI 11.4% to 11.7%) and 20.2% (95% CI 18.1% to 22.3%) respectively between the start of the first non-pharmaceutical intervention in March 2020 and the end of January 2021, while routine referrals had not recovered to prepandemic levels. Reductions in first treatments for newly diagnosed cancers are down 16.3% (95% CI 15.9% to 16.6%). The reduction in the number of 2-week wait referrals and first treatments for all cancer has been largest for those living in poorer areas, despite having a smaller reduction in primary care contact.
Our results further evidence the strain on primary care and the presence of the inverse care law, and the dire need to address the inequalities so sharply brought into focus by the pandemic. We need to address the disconnect between the importance we place on the role of primary care and the resources we devote to it.
为了进一步了解自疫情开始以来新癌症检出率降低方面的不平等现象,我们探索了癌症诊断的途径。我们使用不同的数据集来评估癌症途径的不同阶段:初级保健数据用于初级保健咨询、常规和紧急转诊,以及癌症登记数据分析用于预约和首次治疗。
初级保健和癌症护理。
在这项研究中,我们结合了多个数据集,对癌症途径的不同领域进行了一项基于人群的队列研究。对于初级保健分析,我们使用来自临床实践研究数据链接的 500 万随机患者样本。在转诊后,我们对癌症等待时间数据和国家癌症登记分析服务 COVID-19 数据公平包进行了二次数据分析。
初级保健:所有患者和按患者当地多因素贫困指数五分位数划分的咨询、紧急癌症转诊和常规转诊率,然后是紧急癌症转诊后的预约,以及新诊断癌症的首次治疗。
在 2020 年 3 月首次非药物干预开始至 2021 年 1 月底期间,英格兰的初级保健接触和紧急癌症转诊分别下降了 11.6%(95%可信区间 11.4%至 11.7%)和 20.2%(95%可信区间 18.1%至 22.3%),而常规转诊尚未恢复到大流行前的水平。新诊断癌症的首次治疗减少了 16.3%(95%可信区间 15.9%至 16.6%)。尽管初级保健接触减少幅度较小,但在较贫困地区,所有癌症的 2 周内就诊转诊和首次治疗数量减少幅度最大。
我们的结果进一步证明了初级保健的压力和反向医疗保健法的存在,以及迫切需要解决大流行如此尖锐地凸显的不平等问题。我们需要解决我们对初级保健重要性的重视与我们为此投入的资源之间的脱节。